Showing 141 - 160 results of 57,985 for search '(( 5 nn decrease ) OR ((( 50 ((ns decrease) OR (a decrease)) ) OR ( 2 we decrease ))))', query time: 1.05s Refine Results
  1. 141
  2. 142

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…</p>Methods<p>We retrospectively analyzed 237 male gout patients who had two sets of body composition and metabolic measurements within 6 months. …”
  3. 143

    2‑Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2) by Ariel L. Burgio (15069256)

    Published 2023
    “…To develop more potent compounds, we initiated a structure–activity relationship study that identified 2-aminobenzoxazole as a viable scaffold. …”
  4. 144
  5. 145
  6. 146

    DataSheet2_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…The relevance of these data has, however, not been explored to date in humans. In a population study comprising 50 patients with coronary artery disease (CAD) and 50 age-matched control individuals, we analyzed P2RY4 mutations and their potential association with CAD severity and fasting plasma parameters. …”
  7. 147
  8. 148
  9. 149
  10. 150

    DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

    Published 2020
    “…The beneficial effects of glycolytic gene disruptions seen in wild-type animals (refer to <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1D</a>) are mostly eliminated in the <i>daf-16</i> mutant background: median survival is not increased in <i>daf-16</i> animals treated with either RNAi, and the survival curve of <i>daf-16</i> mutants raised on <i>pyk-2(RNAi)</i> is not significantly (n.s.) different than controls (Log-rank test). …”
  11. 151

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…Knockdown of FAM50A decreased cell proliferation ability, the proportion of EdU positive cells, and the number of CRC cell colonies, whereas overexpressing FAM50A promoted proliferative phenotypes. …”
  12. 152
  13. 153

    Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

    Published 2020
    “…<i>elegans</i> ORF designations indicated). We note that, in our hands, disruption of C50F4.2 (<i>pfk-1</i>.…”
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160